Breaking News
Get 55% Off 0
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% each
Unlock Stocks
Close

Axa World Funds - Framlington Switzerland A Capitalisation Chf (0P00000BIZ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
87.050 -0.130    -0.15%
13/11 - Delayed Data. Currency in CHF
Type:  Fund
Market:  Switzerland
ISIN:  LU0087657150 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 282.83M
AXA World Funds - Framlington Switzerland A Capita 87.050 -0.130 -0.15%

0P00000BIZ Holdings

 
Comprehensive information about top holdings and Key Holding Information for the AXA World Funds - Framlington Switzerland A Capita (0P00000BIZ) fund. Our AXA World Funds - Framlington Switzerland A Capita portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 2.760 2.770 0.010
Shares 97.240 97.240 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 12.866 18.218
Price to Book 2.936 3.302
Price to Sales 2.335 2.090
Price to Cash Flow 15.013 14.079
Dividend Yield 2.366 2.883
5 Years Earnings Growth 8.290 10.583

Sector Allocation

Name  Net % Category Average
Healthcare 28.180 30.261
Financial Services 18.720 20.102
Industrials 15.360 16.155
Consumer Defensive 14.030 13.822
Consumer Cyclical 7.440 5.353
Basic Materials 6.630 8.377
Technology 4.910 3.826
Real Estate 2.150 2.086
Communication Services 1.870 2.727
Utilities 0.720 1.226

Region Allocation

  • Europe Developed
  • Developed Markets

Top Holdings

Number of long holdings: 36

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Roche Holding Participation CH0012032048 9.43 261.90 -0.46%
  Nestle CH0038863350 9.21 79.18 +1.88%
  Novartis CH0012005267 7.30 92.60 +0.71%
  UBS Group CH0244767585 5.41 28.19 +0.43%
  Zurich Insurance Group CH0011075394 4.29 525.80 +1.08%
  Julius Baer CH0102484968 4.26 53.96 +0.45%
  Straumann Holding AG CH1175448666 4.15 112.65 +2.60%
  SIG Group CH0435377954 3.90 17.68 +1.90%
  ABB CH0012221716 3.86 50.02 +0.62%
  Barry Callebaut CH0009002962 3.39 1,353.0 -1.02%

Top Equity Funds by AXA Funds Management S.A.

  Name Rating Total Assets YTD% 3Y% 10Y%
  Framlington Switzerland A Distribuc 282.83M -13.41 8.73 10.15
  Framlington Switzerland F Capitalis 282.83M -13.13 9.55 10.98
  Framlington Switzerland F Distribut 282.83M -13.14 9.55 10.98
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00000BIZ Comments

Write your thoughts about Axa World Funds - Framlington Switzerland A Capitalisation Chf
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email